Drugs / KQB368
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07542704 | May 2026 → Dec 2029 expected | colorectal cancer, non-small cell lung carcinoma, uterine cancer | Kumquat Biosciences Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KQB368 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07542704 ↗ |
| Route | Oral | “Oral KQB368” NCT07542704 ↗ |